Market Need Growing demand in neurogenic bladder and chronic urinary retention presents a clear target for UroDev Medical’s IntelliFlow. Potential sales opportunities exist with urology clinics, rehabilitation centers, home healthcare providers, and hospitals seeking innovative bladder management solutions for patients with urinary retention.

Strategic Positioning Small team and early stage revenue under one million highlight a plug-and-play growth path for distribution partnerships, white-label opportunities, and direct-to-clinic pilots. Focus on regional hospital networks and specialty urology practices to maximize adoption with limited sales bandwidth.

Expansion Ground Relocation to Minneapolis and leadership continuity with a seasoned CEO and new board member indicate stable governance and potential for regional sales push in the Upper Midwest, leveraging existing healthcare networks and procurement channels.

Tech & Platform A tech-forward infrastructure using Google Cloud and CDN capabilities can support remote product support, data integration, and usage analytics for commissioning pilots. This can be leveraged to offer outcomes tracking and value-based selling to health systems.

Investment & Partners With $13M in funding and a clear product roadmap, there is an opportunity to pursue strategic collaborations with medical device distributors, catheter and urology supply chains, and payer-facing pilots to accelerate market access and scale adoption.